Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8150
0.00 (0.00%)
Aug 27, 2026, 1:52 PM HKT

HKG:0460 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,0633,5613,5223,7793,8295,682
Short-Term Investments
150.1166.11144130--
Trading Asset Securities
344.49350.68110.58589.02962.99109.3
Cash & Short-Term Investments
3,5583,9773,7774,4984,7925,792
Cash Growth
-1.14%5.30%-16.02%-6.14%-17.26%17.32%
Accounts Receivable
2,3721,156593.93397.82522.25779.07
Other Receivables
-292.02303.21262.32342.67100.36
Receivables
2,3721,7271,3051,045977.611,094
Inventory
559.75617.73417557.32606.7715.3
Other Current Assets
158.94331.16218.32103.61174.23140.09
Total Current Assets
6,6496,6535,7186,2046,5507,741
Property, Plant & Equipment
2,3972,4702,6352,8422,9984,093
Long-Term Investments
1,2621,165918.041,004907.34972.53
Goodwill
1.851.851.851.851.8514.17
Other Intangible Assets
997.56435.64598.76655.52594.1445.8
Long-Term Deferred Tax Assets
39.7441.4132.1331.7796.77303.46
Long-Term Deferred Charges
-518.13242.97120.4432.36164.3
Other Long-Term Assets
288.99243.15262.32359.63393.46393.84
Total Assets
11,63611,63210,53211,53512,14114,496

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,788422.71273.18220.61205.78118.91
Accrued Expenses
-477.54490.06504.92700.081,077
Short-Term Debt
----25.830
Current Portion of Long-Term Debt
322.2216.56169.29269.68315.17170
Current Portion of Leases
17.0720.5514.0624.521.35.19
Current Income Taxes Payable
89.29122.5263.9744.2167.86111.25
Current Unearned Revenue
87.01102.46110.02143.05175.92214.11
Other Current Liabilities
1,3912,3282,1902,9001,021775.11
Total Current Liabilities
3,6953,6903,3104,1072,5332,502
Long-Term Debt
559.74695.44714.04905.03848.67844.75
Long-Term Leases
6.5939.1445.3851.9879.9431.46
Long-Term Unearned Revenue
239.9303.39313.31163.28135.8182.34
Long-Term Deferred Tax Liabilities
43.573.695.2670.3299.04222.39
Other Long-Term Liabilities
129.38-1,1941,1012,8041,663
Total Liabilities
4,6744,7325,5826,3986,5015,346

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
77.0677.0677.0677.0677.0677.06
Additional Paid-In Capital
3,8823,8823,8823,8823,8823,882
Retained Earnings
824.261,060941.21,3361,6914,922
Treasury Stock
-284.65-242.73-54.11-33.81--
Comprehensive Income & Other
1,6501,073-474.2-829.01-913.86-597.15
Total Common Equity
6,1495,8494,3724,4324,7378,284
Minority Interest
812.571,051577.05704.89902.83865.92
Shareholders' Equity
6,9626,9004,9495,1375,6409,150
Total Liabilities & Equity
11,63611,63210,53211,53512,14114,496

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
905.59971.69942.771,2511,2911,081
Net Cash (Debt)
2,6523,0062,8343,2463,5014,710
Net Cash Growth
3.13%6.05%-12.70%-7.27%-25.67%12.64%
Net Cash Per Share
0.290.330.310.350.380.50
Filing Date Shares Outstanding
9,0249,0429,2449,2829,3309,330
Total Common Shares Outstanding
9,0249,0429,2449,2829,3309,330
Working Capital
2,9542,9632,4072,0974,0175,240
Book Value Per Share
0.680.650.470.480.510.89
Tangible Book Value
5,1505,4123,7723,7754,1417,824
Tangible Book Value Per Share
0.570.600.410.410.440.84
Buildings
-3,4313,5263,5393,5962,956
Machinery
-1,6411,6351,5721,5051,288
Construction In Progress
-203.06205.93295.53346.87819.92